SP1–CD44 signaling modulates PPP-associated metabolism and gemcitabine sensitivity in pancreatic cancer cells

Guiwei Xu, Tingwei Deng, A.M. Abd El-Aty, Shengwei Jiang, Mingyue Deng, Wei Zhang, Peng Gong

Open source

DOI
10.1016/j.bcp.2026.118602
Published
2026-11
Container
Biochemical Pharmacology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.bcp.2026.118602,
  title = {SP1–CD44 signaling modulates PPP-associated metabolism and gemcitabine sensitivity in pancreatic cancer cells},
  author = {Guiwei Xu and Tingwei Deng and A.M. Abd El-Aty and Shengwei Jiang and Mingyue Deng and Wei Zhang and Peng Gong},
  year = {2026},
  journal = {Biochemical Pharmacology},
  doi = {10.1016/j.bcp.2026.118602},
  url = {https://doi.org/10.1016/j.bcp.2026.118602}
}

RIS

TY  - JOUR
TI  - SP1–CD44 signaling modulates PPP-associated metabolism and gemcitabine sensitivity in pancreatic cancer cells
AU  - Guiwei Xu
AU  - Tingwei Deng
AU  - A.M. Abd El-Aty
AU  - Shengwei Jiang
AU  - Mingyue Deng
AU  - Wei Zhang
AU  - Peng Gong
PY  - 2026
JO  - Biochemical Pharmacology
DO  - 10.1016/j.bcp.2026.118602
UR  - https://doi.org/10.1016/j.bcp.2026.118602
ER  - 

APA

Xu, G., Deng, T., El-Aty, A. A., Jiang, S., Deng, M., Zhang, W., & Gong, P. (2026). SP1–CD44 signaling modulates PPP-associated metabolism and gemcitabine sensitivity in pancreatic cancer cells. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2026.118602

Source records